iOnctura Raises EUR 15 Million in Series A Financing to Progress its Pipeline into Clinical Development

AMSTERDAM, Jan. 23, 2020 -- (Healthcare Sales & Marketing Network) -- iOnctura B.V., a clinical stage biopharmaceutical company, developing a pipeline of next generation molecules targeting cancer and fibrosis, announces today the closing of a EUR 15 mill... Biopharmaceuticals, Oncology, Venture Capital, Personnel iOnctura
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news